-
1
-
-
0026596901
-
Potent versus mild acid suppression in peptic ulcer disease
-
Howden CW. Potent versus mild acid suppression in peptic ulcer disease. Hepatogastroenteroly 1992; 39: 45-6.
-
(1992)
Hepatogastroenteroly
, vol.39
, pp. 45-46
-
-
Howden, C.W.1
-
2
-
-
0023617192
-
Acid suppression in duodenal ulcer: A meta-analysis to define optimal dosing with antisecretory drugs
-
Jones DB, Howden CW, Burget DW, Kerr GD, Hunt RH. Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs. Gut 1987; 28: 1120-7.
-
(1987)
Gut
, vol.28
, pp. 1120-1127
-
-
Jones, D.B.1
Howden, C.W.2
Burget, D.W.3
Kerr, G.D.4
Hunt, R.H.5
-
3
-
-
0032976315
-
Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease
-
DeVault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am. J. Gastroenterol. 1999; 94: 1434-42.
-
(1999)
Am. J. Gastroenterol.
, vol.94
, pp. 1434-1442
-
-
Devault, K.R.1
Castell, D.O.2
-
4
-
-
0028890445
-
Optimizing acid suppression for treatment of acid-related diseases
-
Hunt RH, Cederberg C, Dent J et al. Optimizing acid suppression for treatment of acid-related diseases. Dig. Dis. Sci. 1995; 40 (Suppl. 2): 24-49.
-
(1995)
Dig. Dis. Sci.
, vol.40
, Issue.SUPPL. 2
, pp. 24-49
-
-
Hunt, R.H.1
Cederberg, C.2
Dent, J.3
-
5
-
-
0026803020
-
Appropriate acid suppression for the management of gastro-oesophageal reflux disease
-
Bell NJ, Burget D, Howden CW, Wilkinson J, Hunt RH. Appropriate acid suppression for the management of gastro-oesophageal reflux disease. Digestion 1992; 51 (Suppl. 1): 59-67.
-
(1992)
Digestion
, vol.51
, Issue.SUPPL. 1
, pp. 59-67
-
-
Bell, N.J.1
Burget, D.2
Howden, C.W.3
Wilkinson, J.4
Hunt, R.H.5
-
6
-
-
0028243453
-
Comparison of acid inhibition by either oral high-dose ranitidine or omeprazole
-
Hurlimann S, Abbuhl B, Inauen W, Halter F. Comparison of acid inhibition by either oral high-dose ranitidine or omeprazole. Aliment. Pharmacol. Ther. 1994; 8: 193-201.
-
(1994)
Aliment. Pharmacol. Ther.
, vol.8
, pp. 193-201
-
-
Hurlimann, S.1
Abbuhl, B.2
Inauen, W.3
Halter, F.4
-
7
-
-
10744228067
-
The comparative effects of single intravenous doses of omeprazole and famotidine on intragastric pH
-
Abe Y, Inamori M, Togawa J et al. The comparative effects of single intravenous doses of omeprazole and famotidine on intragastric pH. J. Gastroenterol. 2004; 39: 21-5.
-
(2004)
J. Gastroenterol.
, vol.39
, pp. 21-25
-
-
Abe, Y.1
Inamori, M.2
Togawa, J.3
-
8
-
-
0033458763
-
Standard-dose lansoprazole is more effective than high-dose ranitidine in achieving endoscopic healing and symptom relief in patients with moderately severe reflux oesophagitis
-
Jansen JB, Van Oene JC. Standard-dose lansoprazole is more effective than high-dose ranitidine in achieving endoscopic healing and symptom relief in patients with moderately severe reflux oesophagitis. Aliment. Pharmacol. Ther. 1999; 13: 1611-20.
-
(1999)
Aliment. Pharmacol. Ther.
, vol.13
, pp. 1611-1620
-
-
Jansen, J.B.1
Van Oene, J.C.2
-
9
-
-
0029986784
-
The comparative effects of single intravenous doses of cimetidine, ranitidine, famotidine, and omeprazole on intragastric pH
-
Chassany O, Bergmann JF, Simoneau G, Elouaer-Blanc L, Segrestaa JM, Caulin C. The comparative effects of single intravenous doses of cimetidine, ranitidine, famotidine, and omeprazole on intragastric pH. Curr. Ther. Res. 1996; 57: 159-67.
-
(1996)
Curr. Ther. Res.
, vol.57
, pp. 159-167
-
-
Chassany, O.1
Bergmann, J.F.2
Simoneau, G.3
Elouaer-Blanc, L.4
Segrestaa, J.M.5
Caulin, C.6
-
10
-
-
0026612823
-
Does H2 receptor antagonist-resistant ulcer exist? A review based on bioavailability in man
-
Kawai K. Does H2 receptor antagonist-resistant ulcer exist? A review based on bioavailability in man. Gastroenterol. Jpn 1992; 27: 418-23.
-
(1992)
Gastroenterol. Jpn.
, vol.27
, pp. 418-423
-
-
Kawai, K.1
-
11
-
-
0037300057
-
Influence of lansoprazole, famotidine, roxatidine and rebamipide administration on the urea breath test for the diagnosis of Helicobacter pylori infection
-
Adachi K, Fujishiro H, Mihara T, Komazawa Y, Kinoshita Y. Influence of lansoprazole, famotidine, roxatidine and rebamipide administration on the urea breath test for the diagnosis of Helicobacter pylori infection. J. Gastroenterol Hepatol 2003; 18: 168-71.
-
(2003)
J. Gastroenterol. Hepatol.
, vol.18
, pp. 168-171
-
-
Adachi, K.1
Fujishiro, H.2
Mihara, T.3
Komazawa, Y.4
Kinoshita, Y.5
-
12
-
-
0036709389
-
Comparative evaluation of urine-based and other minimally invasive methods for the diagnosis of Helicobacter pylori infection
-
Adachi K, Kawamura A, Ono M et al. Comparative evaluation of urine-based and other minimally invasive methods for the diagnosis of Helicobacter pylori infection. J. Gastroenterol 2002; 37: 703-8.
-
(2002)
J. Gastroenterol.
, vol.37
, pp. 703-708
-
-
Adachi, K.1
Kawamura, A.2
Ono, M.3
-
13
-
-
0038727629
-
Tolerance to famotidine and ranitidine treatment after 14 days of administration in healthy subjects without Helicobacter pylori infection
-
Komazawa Y, Adachi K, Mihara T et al. Tolerance to famotidine and ranitidine treatment after 14 days of administration in healthy subjects without Helicobacter pylori infection. J. Gastroenterol. Hepatol. 2003; 18: 678-82.
-
(2003)
J. Gastroenterol. Hepatol.
, vol.18
, pp. 678-682
-
-
Komazawa, Y.1
Adachi, K.2
Mihara, T.3
-
14
-
-
0029157168
-
Comparison of gastric mucosal surface pH response times after intravenous administration of histamine2-receptor antagonists
-
Katsu K, Yabe S. Comparison of gastric mucosal surface pH response times after intravenous administration of histamine2-receptor antagonists. Clin. Ther. 1995; 17: 433-40.
-
(1995)
Clin. Ther.
, vol.17
, pp. 433-440
-
-
Katsu, K.1
Yabe, S.2
-
15
-
-
0028915876
-
Effect of Helicobacter pylori status on intragastric pH during treatment with omeprazole
-
Verdu EF, Armstrong D, Fraser R et al. Effect of Helicobacter pylori status on intragastric pH during treatment with omeprazole. Gut 1995; 36: 539-43.
-
(1995)
Gut
, vol.36
, pp. 539-543
-
-
Verdu, E.F.1
Armstrong, D.2
Fraser, R.3
-
16
-
-
0029047385
-
Review article: The development of atrophic gastritis-Helicobacter pylori and the effects of acid suppressive therapy
-
Kuipers EJ, Lee A, Klinkenberg-Knol EC, Meuwissen SG. Review article: the development of atrophic gastritis-Helicobacter pylori and the effects of acid suppressive therapy. Aliment. Pharmacol. Ther. 1995; 9: 331-40.
-
(1995)
Aliment. Pharmacol. Ther.
, vol.9
, pp. 331-340
-
-
Kuipers, E.J.1
Lee, A.2
Klinkenberg-Knol, E.C.3
Meuwissen, S.G.4
-
17
-
-
0033023098
-
Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole
-
Holtmann G, Cain C, Malfertheiner P. Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole. Gastroenterology 1999; 117: 11-16.
-
(1999)
Gastroenterology
, vol.117
, pp. 11-16
-
-
Holtmann, G.1
Cain, C.2
Malfertheiner, P.3
-
18
-
-
0033859704
-
Helicobacter pylori infection influences nocturnal gastric acid breakthrough
-
Katsube T, Adachi K, Kawamura A et al. Helicobacter pylori infection influences nocturnal gastric acid breakthrough. Aliment. Pharmacol Ther. 2000; 14: 1049-56.
-
(2000)
Aliment. Pharmacol Ther.
, vol.14
, pp. 1049-1056
-
-
Katsube, T.1
Adachi, K.2
Kawamura, A.3
-
19
-
-
0032763735
-
Helicobacter pylori infection inhibits reflux esophagitis by inducing atrophic gastritis
-
Koike T, Ohara S, Sekine H et al Helicobacter pylori infection inhibits reflux esophagitis by inducing atrophic gastritis. Am. J. Gastroenterol 1999; 94: 3468-72.
-
(1999)
Am. J. Gastroenterol.
, vol.94
, pp. 3468-3472
-
-
Koike, T.1
Ohara, S.2
Sekine, H.3
|